A Phase 4 Two Dose Level Study of Naglazyme(TM) (Galsulfase) in Infants With MPS VI

Clinical trial NCT00299000 · COMPLETED

Trial details

NCT number: NCT00299000
Sponsor: BioMarin Pharmaceutical
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Mucopolysaccharidosis VI Maroteaux-Lamy Syndrome

Start date: 2006-05-01
Primary completion: 2009-04-01
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.